Article
Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers.
British journal of clinical pharmacology - 1 Jan 2014
Markert Christoph, Schweizer Yvonne, Hellwig Regina, Wirsching Theresia, Riedel Klaus-Dieter, Burhenne Juergen, Weiss Johanna, Mikus Gerd, Haefeli Walter E
Abstract excerpt
AIMS: The aim of this study was to assess the effect of the cytochrome P450 (CYP) 3A4 and organic anion-transporting polypeptide (OATP) 1B1 inhibitor clarithromycin on the pharmacokinetics of bosentan. We also aimed to evaluate the impact of CYP2C9 and SLCO1B1 (encoding for OATP1B1) genotypes and their combination. METHODS: We assessed the effect of the OATP and CYP3A inhibitor clarithromycin on bosentan...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
